TREAT-NMD Conference

Vancouver, Canada - June 2022

  • Welcome
  • Programme
    • Programme
    • Organizing Committee
  • Registration
    • Registration fees
    • Our Conference App
  • Abstracts
  • Venue
  • Our Sponsors
    • Sponsor us
    • Past Conferences
  • Accommodation in Vancouver
  • Visiting Vancouver
    • Travelling to Vancouver
    • Whilst you’re in Vancouver

Markus Rüegg

Markus Rüegg is a biochemist by training and now Professor of Neurobiology at the Biozentrum of the University of Basel. His main research interests are the molecular pathways involved in muscle wasting diseases in general. He was a founding member of MyoContract Ltd, which later became Santhera Pharmaceuticals Ltd, and was a partner of TREAT-NMD. Markus is a member of scientific panels of Muscular Dystrophy UK and Cure CMD and he is chairman of the scientific council of the Swiss Foundation for Research on Muscle Diseases (FSRMM).

Connect and interact


To maximise your conference experience we are developing a smartphone app to help you not only find out about the conference but also make those all important  connections. More information about the app will be published soon.

  - find out how -  


 


Deprecated: genesis_attributes_nav is deprecated since version 3.1.0! Use \StudioPress\Genesis\Functions\Schema\nav_primary instead. in /home/customer/www/treat-nmd-conference.org/public_html/conf/wp-includes/functions.php on line 5323
  • Welcome
  • Programme
  • Registration
  • Abstracts
  • Venue
  • Our Sponsors
  • Accommodation in Vancouver
  • Visiting Vancouver

Copyright © 2022 · Privacy Policy · TREAT-NMD · Log in